top of page
Graph

Market-Driven Investment in Precision Diagnostics

INVESTING IN EARLY-STAGE DIAGNOSTIC COMPANIES 

We invest in Seed and Series A diagnostic companies leveraging our understanding of market need, product market fit, capital requirements to commercialize (and exit), market access and commercial strategy.

Pipette Inserted Into Test Tube
MARKET AND CLINICIAN NEEDS
We are diagnostic industry veterans who believe that the
use of data and tools in the form of diagnostics is the key to improving healthcare.

The market in recent years has not been kind to the diagnostics industry,
and too many investors have pulled away, not understanding the path to returns.

We are leaning in, with a focus on understanding the needs of the market
from a clinical and economic perspective - upfront

We leverage our data tools to identify the gaps in the market where
diagnostics can solve problems that the market is incentivized to pay for.

Our Limited Partners are industry leaders who believe in our industry,
understand the requirements, and support our companies to achieve their goals. 
WE SIMPLIFY INVESTMENT IN DIAGNOSTICS
BY STARTING WITH THE PROBLEM
Surgical Lights
Identifying the problem to be solved, and the requirements for a solution

Economic needs of payers and clinical needs of patients and physicians. Alignment of workflow for physicians and experience for patients.​

Revewing Graphs
Valuing the solution to the problem
 

Payers must agree to the economic proposition.

 

Physicians must agree on the clinical utility.​

​

Stack of Files
Confirming the evidence required to pay for the solution

Consensus on evidence required to demonstrate economic and clinical utility.

​

​

OUR TEAM

We are a team of operators who are experts in every aspect in which we invest. We are physicians, scientists, and commercial leaders who have financed and delivered diagnostic technologies to the market.

Over 10 decades of our collective experience inspires our unique investment philosophy to create valuable diagnostics companies in a capital efficient manner.

Lena LinkedIN.jpeg

Lena
Chaihorsky

Principal

Blake.jpeg

J. Blake
Long, MD, MBA

Principal

Mike.jpeg

Mike
Fried, MBA, MHI

Principal

Mashael_edited.jpg

Mashael
AlHegelan, MD, MBA

Principal​

SPEAKING ENGAGEMENTS, CONFERENCES AND EVENTS
1730300729666_edited.jpg
November 6, 2024
McDermott Life Sciences Dealmaking Symposium 2024
DxPx Europe.png
January 26, 2025
DxPx Europe
RESI-JPM-2025-1100PX.jpg
January 14, 2025
RESI JPM Healthcare 2025 Conference, oncology panel
Hevolution 2.jpeg
February 4-5, 2025
Hevolution
Concept of Robotic Arm

BOSTON, MA

DURHAM, NC

SAN DIEGO, CA

© 2024 10EdisonCapital

© 2024 10EdisonCapital

bottom of page